Streetbeat News

Price Targets

RUN

KeyBanc Capital Markets analyst Sophie Karp has reiterated the Overweight rating on Sunrun Inc. (NASDAQ:RUN), but lowered the price target from $27 to $24. This follows Sunrun's mixed Q2 results, with revenue missing estimates but earnings beating them. Despite satisfactory customer growth, Sunrun's revenues and cash flow generation were lower due to a gradual recovery in CA demand and post-inflationary working capital hangover. The company is sticking to its original 2023 guidance, leading the analyst to pare back 2023 estimates.

Portfolio Pulse from Nabaparna Bhattacharya

August 17, 2023 | 6:55 pm

CRSP

Citigroup analyst Yigal Nochomovitz has upgraded CRISPR Therapeutics (NASDAQ:CRSP) from Neutral to Buy, while maintaining a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 6:35 pm

PGR

BMO Capital Markets analyst Michael Zaremski reiterated the Market Perform rating on Progressive Corporation (NYSE:PGR), raising the price target from $125 to $130. The company's July results were driven by an improvement in the core auto loss ratios. Zaremski predicts that the company's FY24 EPS will be boosted by significant expense/ad spend cuts.

Portfolio Pulse from Nabaparna Bhattacharya

August 17, 2023 | 6:14 pm

AUTL

GILD

Truist has raised the price target for Autolus Therapeutics PLC (NASDAQ:AUTL) from $6 to $9 with a Buy rating on Obe-cel's prospects. The analyst sees Obe-cel as a potential new standard of care for acute lymphoblastic leukemia (ALL), superior to Tecartus sold by Kite Pharma, a Gilead Sciences Inc (NASDAQ:GILD) subsidiary. Autolus is expected to get its first CAR-T approved next year. The analyst increased Obe-cel market penetration to 60% and forecasts peak sales of $300 million.

Portfolio Pulse from Vandana Singh

August 17, 2023 | 5:22 pm

HAL

UBS has maintained its Buy rating for Halliburton (NYSE:HAL) and increased its price target from $49.00 to $52.00. This new target price represents a 31.3% increase from the current share price. Halliburton's shares have risen by 0.8% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

CNP

CenterPoint Energy (NYSE:CNP) has received various analyst ratings in the last quarter, with 3 bullish, 2 somewhat bullish, and 2 indifferent. The average 12-month price target for the company, according to 7 analysts, is $32.14, which has increased by 0.44% over the past month.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

CUZ

Evercore ISI Group has maintained its Outperform rating for Cousins Props (NYSE:CUZ) and raised its price target from $25.00 to $28.00. This would represent a 26.13% increase from the current share price. Cousins Properties Inc is a real estate investment trust mainly involved in the ownership, management, and development of properties in the Southern United States.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

SLN

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Silence Therapeutics (NASDAQ:SLN) and maintained a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 4:42 pm

TJX

Loop Capital analyst Laura Champine maintains a 'Buy' rating on TJX Companies and raises the price target from $95 to $100.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 4:29 pm

ADBE

B of A Securities analyst Brad Sills has upgraded Adobe Inc. (NASDAQ:ADBE) from Neutral to Buy and raised the price target from $575 to $630. The analyst views Adobe as an emerging AI leader and projects its AI revenue to be $300 million in FY24, growing to $960 million by FY26. However, there is uncertainty about the proposed Figma acquisition.

Portfolio Pulse from Shivani Kumaresan

August 17, 2023 | 4:28 pm